Looking back to 90 days ago, Isis Pharmaceuticals, Inc. (NASD: ISIS) priced a 9,000,000 share secondary stock offering at $19.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Tuesday, the stock is now 44.3% higher than the offering price.
Looking back to 90 days ago, Isis Pharmaceuticals, Inc. (NASD: ISIS) priced a 9,000,000 share secondary stock offering at $19.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Tuesday, the stock is now 44.3% higher than the offering price.
Share this Article
Recommended